Physician profile
Jamie Whitehead
NPI 1053553024
$604.58
in general payments reported to CMS, 2019-2025
11 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.07 · 2023: $15.30 · 2024: $167 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $379.70 | 2021-2025 | |
| Averitas Pharma INC. | $51.49 | 2025 | Qutenza |
| Lilly USA, LLC | $31.73 | 2025 | Mounjaro, Zepbound |
| Phathom Pharmaceuticals, INC. | $24.22 | 2024 | Voquezna |
| Hologic Sales and Service, LLC | $21.95 | 2024 | Aptima |
| Incyte Corporation | $20.45 | 2025 | Opzelura |
| Dexcom, INC. | $15.80 | 2021 | |
| Glaxosmithkline, LLC. | $15.30 | 2023 | Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $15.04 | 2024 | Cologuard Collection Kit |
| Alkermes, INC. | $14.75 | 2024 | Vivitrol |
| Xeris Pharmaceuticals, INC. | $14.15 | 2024 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Whitehead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.